Drakenterprises
CardiologyDiabetesFamily MedicineEmergencyOrthopaedicsOtolaryngologyOncologyCross-cutting

Not clinical advice. Clinical Evidence is a current-awareness feed. It is not a clinical decision-support system, not medical advice, and not a substitute for clinical judgment, institutional protocols, or the original sources. Full text, NCCN recommendations, and Cochrane review bodies are not reproduced here.

Home · cross-cutting

NatureArticle

Landmark pancreatic cancer drug shows potential against lung cancer too.

Nature · 09/02/2026

Authors: Ledford, Heidi

Publication types: News

PubMed abstract / permitted excerpt

Nature, Published online: 02 September 2026; doi:10.1038/d41586-026-02745-5 Results bolster hopes that the drug daraxonrasib could prove effective against a variety of tumours.

Full-text bodies are not stored. PubMed metadata and official TOC RSS. No full-text republication.

Clinical Evidence